Target intelligence / Profile preview

Blood circulation activation

Molecular classification
Other
01

Overview

Blood circulation activation" refers to the physiological process of increasing or restoring blood flow in tissues or organs. This effect can be achieved by acting on multiple molecular targets and pathways, including regulation of vascular tone through endothelium-derived signals, activation or inhibition of specific receptors (such as the angiotensin II type 1 receptor for vasoconstriction, or Mas receptor for vasodilation), modulation of ion channels and signaling cascades in smooth muscle cells, and the promotion of angiogenesis or arteriogenesis. Many drugs and therapeutic interventions aim to activate blood circulation by targeting these diverse molecular mechanisms, but the term does not correspond to a single molecule, receptor, or protein. Key clarification: - "Blood circulation activation" is *not* a molecular target—rather, it refers to a complex physiological outcome mediated by diverse molecular pathways and receptors. If structuring data on molecular targets, this entry should be flagged as incorrect or insufficiently specific for database purposes.

Other names
Blood flow activationBlood circulation enhancementCirculatory stimulation
02

Mechanism of action

Nitric oxide/cGMP pathway activation; Inhibition of angiotensin II type 1 receptor (AT1R); Calcium channel inhibition; ATP-mediated vasodilation (by red blood cells); Endothelial-derived hyperpolarization

03

Biological functions

VasodilationBlood vessel growth (angiogenesis, arteriogenesis, vasculogenesis)Regulation of vascular toneActivation of endothelial and smooth muscle signaling
04

Disease associations

Cardiovascular diseaseStrokeHypertensionIschemia
05

Safety considerations

HypotensionBleeding riskReflex tachycardiaOff-target effects (depends on drugs or pathways modulated)
06

Interacting drugs

Vasodilators (e.g., nitroglycerin)

5 more in the full profile.

07

Biomarkers

Blood pressureFlow-mediated dilation (FMD)Circulating nitric oxide metabolitesNot specific to a single molecule

Beyond the preview

Go deeper on Blood circulation activation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood circulation activation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call